ACM

Aquilo Capital Management Portfolio holdings

AUM $37.1M
This Quarter Return
-2.28%
1 Year Return
-36.49%
3 Year Return
+1.32%
5 Year Return
+39.69%
10 Year Return
–
AUM
$407M
AUM Growth
+$407M
Cap. Flow
+$31.3M
Cap. Flow %
7.7%
Top 10 Hldgs %
93.88%
Holding
16
New
1
Increased
7
Reduced
1
Closed
1

Top Buys

1
MRUS icon
Merus
MRUS
$28.5M
2
ARVN icon
Arvinas
ARVN
$17.1M
3
BPMC
Blueprint Medicines
BPMC
$13.3M
4
ARWR icon
Arrowhead Research
ARWR
$11.4M
5
FDMT icon
4D Molecular Therapeutics
FDMT
$9M

Top Sells

1
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
$49.5M
2
QURE icon
uniQure
QURE
$13.3M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
SPRO icon
1
Spero Therapeutics
SPRO
$116M
$79.5M 9.01%
4,964,181
+400,493
+9% +$6.41M
BPMC
2
DELISTED
Blueprint Medicines
BPMC
$69.1M 7.84%
645,539
+123,866
+24% +$13.3M
ARWR icon
3
Arrowhead Research
ARWR
$3.05B
$46.4M 5.27%
700,426
+172,500
+33% +$11.4M
ARVN icon
4
Arvinas
ARVN
$568M
$46.3M 5.25%
563,451
+208,740
+59% +$17.1M
RGNX icon
5
Regenxbio
RGNX
$451M
$33.1M 3.76%
1,013,596
+174,457
+21% +$5.7M
FDMT icon
6
4D Molecular Therapeutics
FDMT
$288M
$33.1M 3.76%
1,509,944
+410,000
+37% +$9M
MRUS icon
7
Merus
MRUS
$4.98B
$28.5M 3.23%
+896,502
New +$28.5M
AMYT
8
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$17.7M 2.01%
1,640,000
+250,000
+18% +$2.7M
QURE icon
9
uniQure
QURE
$896M
$14M 1.59%
676,206
-643,307
-49% -$13.3M
DNTH icon
10
Dianthus Therapeutics
DNTH
$759M
$14M 1.59%
3,155,082
– –
PVLA
11
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
$12.1M 1.37%
3,196,527
– –
ARGX icon
12
argenx
ARGX
$43.6B
$7.77M 0.88%
22,200
– –
GMAB icon
13
Genmab
GMAB
$15.3B
$5.04M 0.57%
127,500
– –
SPY icon
14
SPDR S&P 500 ETF Trust
SPY
$658B
– –
0
– –
XBI icon
15
SPDR S&P Biotech ETF
XBI
$5.07B
– –
0
– –
DRNA
16
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
– –
-2,456,595
Closed -$49.5M